Brief: CStone Pharmaceuticals Says Co & Dotbio Pte Ltd Have Entered Into Collaboration Agreement On November 8
09/11/2021 24:23
Nov 9 (Reuters) - CStone Pharmaceuticals 2616.HK :
* CO & DOTBIO PTE LTD HAVE ENTERED INTO COLLABORATION
AGREEMENT ON
NOVEMBER 8
* AGREEMENT TO JOINTLY DEVELOP UP TO THREE ANTIBODY
THERAPIES
Further company coverage: 2616.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026